Bio-Rad Laboratories, Inc. announced the completion of its acquisition of all equity interests in Stilla Technologies, a French corporation. The acquisition was finalized on June 30, 2025, following a binding offer made by Bio-Rad on February 13, 2025. This strategic move is expected to enhance Bio-Rad's capabilities and offerings in the biotechnology sector.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Rad Laboratories Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000012208-25-000032), on June 30, 2025, and is solely responsible for the information contained therein.